What is the initial dose of regular insulin for a patient with severe hyperglycemia (glucose level of 350) and an A1C above 15, weighing 73.2 kg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Initial Insulin Dosing for Severe Hyperglycemia

For a patient with severe hyperglycemia (glucose 350 mg/dL) and A1C above 15 weighing 73.2 kg, the initial regular insulin dose should be 0.1 units/kg/hour as an intravenous infusion, which equals approximately 7.3 units/hour, or if using subcutaneous insulin, start with a total daily dose of 0.5-0.6 units/kg/day (36-44 units), with 50% as basal and 50% as prandial insulin.

Initial Management Approach

  • For patients with severe hyperglycemia (glucose ≥300-350 mg/dL) and very high A1C (≥10-12%), immediate insulin therapy is strongly recommended 1
  • With glucose of 350 mg/dL and A1C above 15%, this patient has severe hyperglycemia requiring prompt insulin initiation rather than oral agents 1, 2
  • For this 73.2 kg patient, the recommended initial approach depends on clinical presentation:
    • If symptomatic with polyuria, polydipsia, or weight loss: start with basal insulin while initiating metformin 1
    • If showing signs of metabolic decompensation: use intravenous insulin initially 1

Dosing Calculations

  • For intravenous insulin in severe hyperglycemia:

    • Initial dose: 0.1 units/kg/hour = 7.3 units/hour 1, 2
    • Monitor glucose every 1-2 hours and adjust insulin rate to achieve target glucose of 140-180 mg/dL 1
  • For subcutaneous insulin regimen:

    • Total daily insulin dose: 0.5-0.6 units/kg/day = 36-44 units total 1, 2
    • Distribute as 50% basal (18-22 units) and 50% prandial (18-22 units divided between meals) 1
    • Basal insulin: Start with 18-22 units of glargine once daily or NPH twice daily 1, 2
    • Prandial insulin: Start with 6-7 units of regular insulin before each meal 1, 2

Titration Protocol

  • Increase basal insulin by 2 units every 3 days until fasting glucose reaches target (70-130 mg/dL) without hypoglycemia 2
  • Adjust prandial insulin by 1-2 units or 10-15% twice weekly based on post-meal glucose readings 1
  • If hypoglycemia occurs, reduce the corresponding insulin dose by 10-20% 1, 2
  • Monitor blood glucose before meals and at bedtime to guide adjustments 2

Important Considerations

  • Assess for ketosis/ketoacidosis, which would necessitate more aggressive insulin therapy and fluid resuscitation 1, 3
  • Screen for hyperosmolar hyperglycemic state if glucose exceeds 600 mg/dL 1, 3
  • Continue metformin (if not contraindicated) alongside insulin therapy to improve insulin sensitivity 1, 2
  • Provide comprehensive education on insulin administration, glucose monitoring, and hypoglycemia management 1, 2

Monitoring and Follow-up

  • Check glucose levels frequently during initial management - every 1-2 hours if intravenous insulin is used, or 4 times daily with subcutaneous regimen 1, 2
  • Once glucose levels stabilize below 300 mg/dL on intravenous insulin, transition to subcutaneous insulin with overlap to prevent rebound hyperglycemia 1
  • Reassess A1C after 3 months of therapy 1, 2

This patient's severe hyperglycemia requires immediate insulin therapy rather than stepwise oral agent approach. The high A1C above 15% indicates prolonged, significant hyperglycemia that will respond best to insulin, with the goal of preventing acute complications and gradually improving glycemic control.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Insulin Therapy Adjustments for Uncontrolled Glucose Levels

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hyperosmolar Hyperglycemic State.

American family physician, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.